Skip to main content
Fig. 2 | Stem Cell Research & Therapy

Fig. 2

From: Impact of one versus two doses of mesenchymal stromal cells on lung and cardiovascular repair in experimental emphysema

Fig. 2

Two doses of MSCs led to further mitigation in BALF cellularity compared to a one-dose regimen. a Total leukocytes, b neutrophils, c macrophages, d lymphocytes, e CD4+ T cells, and f CD8+ T cell counts in BALF. CTRL control mice, E emphysema mice, SAL saline-treated mice, MSC MSC-treated group, MSCs mesenchymal stromal cells, BALF bronchoalveolar lavage fluid. One-way ANOVA followed by Tukey’s test was used for statistical comparison. Data are presented as means ± SD. N = 10 animals/group. *Significantly different from CTRL (p < 0.05). #Significantly different from E-SAL (p < 0.05)

Back to article page

Stem Cell Research & Therapy

ISSN: 1757-6512